BL
IRD

Bleichroeder LP’s Opus Genetics IRD Stock Holding History

Bleichroeder LP’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.35M Hold
736,842
– – 0.58% 23
2025
Q4 		$1.48M Hold
736,842
– – 0.26% 31
2025
Q3 		$1.22M Hold
736,842
– – 0.24% 33
2025
Q2 		$694K Hold
736,842
– – 0.17% 37
2025
Q1 		$723K Buy
+736,842
New +$823K 0.19% 33

Other funds holding IRD

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bleichroeder LP's IRD Position: Q1 2026 in Review

Bleichroeder LP held its Opus Genetics (IRD) position steady in Q1 2026 at 736,842 shares worth $3.35M. The position accounts for 0.58% of the portfolio, ranked #23.

Bleichroeder LP first reported a position in IRD in Q1 2025 and has held it in 5 quarters since. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

  • Bleichroeder LP held 736,842 shares of Opus Genetics worth $3.35M as of Q1 2026.
  • Bleichroeder LP left its Opus Genetics share count unchanged in Q1 2026.
  • Opus Genetics made up 0.58% of Bleichroeder LP's portfolio in Q1 2026, its #23 holding.
  • Bleichroeder LP first reported a position in Opus Genetics in Q1 2025 and has held it in 5 quarters since.
  • 79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on Bleichroeder LP's 13F filing for Q1 2026, filed 14 May 2026.